Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 281

Related Articles by Review for PubMed (Select 15520426)

1.

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text.

PMID:
15520426
2.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
3.

Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.

Epstein BJ, Gums JG.

Ann Pharmacother. 2005 Mar;39(3):470-80. Epub 2005 Feb 8. Review.

PMID:
15701766
4.
5.
6.
7.

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.

Eur Heart J. 2005 Oct;26(20):2154-8. Epub 2005 Jul 13. Review.

8.
9.

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M.

Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Epub 2008 May 3. Review.

PMID:
18454336
10.
11.

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

Al Khalaf MM, Thalib L, Doi SA.

Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.

PMID:
19178130
12.

Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?

Weber MA.

J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):62-73. Review.

PMID:
12806587
13.
14.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.

PMID:
17984484
16.

Angiotensin receptor blockers for heart failure.

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD003040. doi: 10.1002/14651858.CD003040.pub2. Review.

PMID:
22513909
17.

Angiotensin II-receptor blockers: clinical relevance and therapeutic role.

Rodgers JE, Patterson JH.

Am J Health Syst Pharm. 2001 Apr 15;58(8):671-83. Review. Erratum in: Am J Health Syst Pharm 2001 Sep 1;58(17):1658.

PMID:
11329759
18.

The use of angiotensin receptor blockers in the treatment of chronic heart failure.

Irons BK, Tsikouris JP, Thomas AA.

J Cardiovasc Pharmacol. 2004 Dec;44(6):718-24. Review.

PMID:
15550793
19.

Congestive heart failure: what should be the initial therapy and why?

Chatterjee K.

Am J Cardiovasc Drugs. 2002;2(1):1-6. Review.

PMID:
14727993
20.

ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.

Düsing R, Sellers F.

Curr Med Res Opin. 2009 Sep;25(9):2287-301. doi: 10.1185/03007990903152045. Review.

PMID:
19635044
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk